XTANT MEDICAL HOLDINGS, INC. Payments of Stock Issuance Costs
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Payments of Stock Issuance Costs of $544.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-03-31
- XTANT MEDICAL HOLDINGS, INC. payments of stock issuance costs for the quarter ending 2024-09-30 was $191.00K, a 9.14% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. payments of stock issuance costs for the quarter ending 2023-09-30 was $175.00K, a 57.21% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. payments of stock issuance costs for the quarter ending 2022-09-30 was $409.00K.
- XTANT MEDICAL HOLDINGS, INC. payments of stock issuance costs for the quarter ending 2021-03-31 was $1.93M.
- XTANT MEDICAL HOLDINGS, INC. payments of stock issuance costs for fiscal 2024 was $544.00K, a 210.86% increase from fiscal 2023.
- XTANT MEDICAL HOLDINGS, INC. payments of stock issuance costs for fiscal 2023 was $175.00K, a 59.86% decline from fiscal 2022.
- XTANT MEDICAL HOLDINGS, INC. payments of stock issuance costs for fiscal 2022 was $436.00K, a 77.36% decline from fiscal 2021.
- XTANT MEDICAL HOLDINGS, INC. payments of stock issuance costs for fiscal 2021 was $1.93M.
| Period end | Payments of Stock Issuance Costs 0 month | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|
| 2024-12-31 | $544.00K 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $191.00K 10-Q · filed 2025-11-10 | ||
| 2023-12-31 | $175.00K 10-K · filed 2025-03-06 | ||
| 2023-09-30 | $175.00K 10-Q · filed 2024-11-12 | ||
| 2022-12-31 | $436.00K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $409.00K 10-Q · filed 2023-11-14 | ||
| 2021-12-31 | $1.93M 10-K · filed 2023-03-07 | ||
| 2021-03-31 | $1.93M 10-Q · filed 2022-11-03 | ||
| 2013-06-30 | $400.00K 10-K · filed 2014-03-27 | ||
| 2013-06-10 | $400.00K 10-Q · filed 2014-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |